The top selling biologics market is projected to be worth USD 156 billion by 2030, claims Roots Analysis
October 20, 2021 09:00 ET
|
Roots Analysis
London, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Top Selling Biologics Market, 2021 – 2030” report to its list of offerings. Over the years, around 200...
The biospecimen contract research market is projected to grow at a noteworthy pace till 2030, claims Roots Analysis
September 29, 2021 09:00 ET
|
Roots Analysis
London, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Biospecimen Contract Research Services Market, 2021 – 2030” report to its list of offerings. Given the...
The on-body drug delivery-related intellectual landscape report identifies and analyzes all relevant IP publications, featuring the contributions of both established and emerging technology developers
September 23, 2021 09:00 ET
|
Roots Analysis
London, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art...
The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, growing at an annualized rate of 27.54% during the period 2021-2030, claims Roots Analysis
September 22, 2021 09:00 ET
|
Roots Analysis
London, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Soft Tissue Sarcoma Market: Focus on Angiosarcoma, Chondrosarcoma, and Liposarcoma Market, 2021-2030” report...
The Fc protein and glyco-engineered antibodies market is projected to grow at a CAGR of over 30% during 2021-2030, claims Roots Analysis
September 14, 2021 08:15 ET
|
Roots Analysis
London, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Fc Protein and Glyco-engineered Antibodies Market, 2021-2030” report to its list of offerings. Over time, a...
The pharmaceutical contract research services market, is anticipated to be worth USD 59 billion by 2030, growing at an annualized rate of over 10%, claims Roots Analysis
September 13, 2021 08:25 ET
|
Roots Analysis
London, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical Contract Research Services Market, 2021-2030” report to its list of offerings. Majority of...
The peptide therapeutics market is projected to be worth around USD 41.7 Billion in 2030, claims Roots Analysis
September 09, 2021 08:36 ET
|
Roots Analysis
London, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Peptide Therapeutics Market, 2021 – 2030” report to its list of offerings. Characterized by a rapidly...
The DNA damage response (DDR) targeting therapeutics market is projected to be worth USD 1.07 billion in 2030, growing at an annualized rate of 52.6% during the period 2024-2030, claims Roots Analysis
September 08, 2021 09:00 ET
|
Roots Analysis
London, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “DNA Damage Response Targeting Therapeutics (beyond PARP inhibitors) Market, 2021-2030” report to its list of...
The CRISPR based therapeutics market is projected to be worth around USD 2.2 billion by 2030, growing at an annualized rate of 129.2%, claims Roots Analysis
August 03, 2021 08:31 ET
|
Roots Analysis
London, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “CRISPR based Therapeutics Market, 2021-2030” report to its list of offerings. With over 115 candidates under...
The TIL therapies market is projected to be worth over USD 4.3 billion by 2030, claims Roots Analysis
July 22, 2021 08:45 ET
|
Roots Analysis
London, July 22, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “TIL Therapies Market, 2021-2030” report to its list of offerings. Given the frequently reported inadequacies...